Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-3-5
pubmed:databankReference
pubmed:abstractText
Excess 17beta-estradiol (E2), the most potent of human estrogens, is known to act as a stimulus for the growth of breast tumors. Human estrogenic 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1), which catalyzes the reduction of inactive estrone (E1) to the active 17beta-estradiol in breast tissues, is a key enzyme responsible for elevated levels of E2 in breast tumor tissues. We present here the structure of the ternary complex of 17beta-HSD1 with the cofactor NADP+ and 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin), an equine estrogen used in estrogen replacement therapy. The ternary complex has been crystallized with a homodimer, the active form of the enzyme, in the asymmetric unit. Structural and kinetic data presented here show that the 17beta-HSD1-catalyzed reduction of E1 to E2 in vitro is specifically inhibited by equilin. The crystal structure determined at 3.0-A resolution reveals that the equilin molecule is bound at the active site in a mode similar to the binding of substrate. The orientation of the 17-keto group with respect to the nicotinamide ring of NADP+ and catalytic residues Tyr-155 and Ser-142 is different from that of E2 in the 17beta-HSD1-E2 complex. The ligand and substrate-entry loop densities are well defined in one subunit. The substrate-entry loop adopts a closed conformation in this subunit. The result demonstrates that binding of equilin at the active site of 17beta-HSD1 is the basis for inhibition of E1-to-E2 reduction by this equine estrogen in vitro. One possible outcome of estrogen replacement therapy in vivo could be reduction of E2 levels in breast tissues and hence the reduced risk of estrogen-dependent breast cancer.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-13033838, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-1322895, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-1325275, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-1721669, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-1735607, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-1940311, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-2126197, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-2197967, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-2779584, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-2846351, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-3164708, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-3308940, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-3807364, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-6832147, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7487879, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7525828, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7663947, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7737980, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7742302, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-7922040, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8075637, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8099587, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8243287, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8347566, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8547177, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8615778, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8756321, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8805577, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8805582, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8994190, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-8994882, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-9118119, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-9231808, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-9255744, http://linkedlifedata.com/resource/pubmed/commentcorrection/9927655-9525918
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
840-5
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:9927655-Amino Acid Sequence, pubmed-meshheading:9927655-Animals, pubmed-meshheading:9927655-Binding Sites, pubmed-meshheading:9927655-Crystallography, X-Ray, pubmed-meshheading:9927655-Dimerization, pubmed-meshheading:9927655-Equilin, pubmed-meshheading:9927655-Estradiol Dehydrogenases, pubmed-meshheading:9927655-Humans, pubmed-meshheading:9927655-Least-Squares Analysis, pubmed-meshheading:9927655-Macromolecular Substances, pubmed-meshheading:9927655-Models, Molecular, pubmed-meshheading:9927655-Molecular Sequence Data, pubmed-meshheading:9927655-NADP, pubmed-meshheading:9927655-Protein Conformation, pubmed-meshheading:9927655-Protein Structure, Secondary, pubmed-meshheading:9927655-Recombinant Proteins, pubmed-meshheading:9927655-Spodoptera, pubmed-meshheading:9927655-Transfection
pubmed:year
1999
pubmed:articleTitle
Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
pubmed:affiliation
Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't